These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 27454352)

  • 21. Highly specific determination of IDH status using edited in vivo magnetic resonance spectroscopy.
    Branzoli F; Di Stefano AL; Capelle L; Ottolenghi C; Valabrègue R; Deelchand DK; Bielle F; Villa C; Baussart B; Lehéricy S; Sanson M; Marjanska M
    Neuro Oncol; 2018 Jun; 20(7):907-916. PubMed ID: 29126125
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 2-Hydroxyglutarate MR spectroscopy for prediction of isocitrate dehydrogenase mutant glioma: a systemic review and meta-analysis using individual patient data.
    Suh CH; Kim HS; Jung SC; Choi CG; Kim SJ
    Neuro Oncol; 2018 Nov; 20(12):1573-1583. PubMed ID: 30020513
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 2-hydroxyglutarate detection by magnetic resonance spectroscopy in IDH-mutated patients with gliomas.
    Choi C; Ganji SK; DeBerardinis RJ; Hatanpaa KJ; Rakheja D; Kovacs Z; Yang XL; Mashimo T; Raisanen JM; Marin-Valencia I; Pascual JM; Madden CJ; Mickey BE; Malloy CR; Bachoo RM; Maher EA
    Nat Med; 2012 Jan; 18(4):624-9. PubMed ID: 22281806
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Echo time optimization for J-difference editing of glutathione at 3T.
    Chan KL; Puts NA; Snoussi K; Harris AD; Barker PB; Edden RA
    Magn Reson Med; 2017 Feb; 77(2):498-504. PubMed ID: 26918659
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment Response Assessment in IDH-Mutant Glioma Patients by Noninvasive 3D Functional Spectroscopic Mapping of 2-Hydroxyglutarate.
    Andronesi OC; Loebel F; Bogner W; Marjańska M; Vander Heiden MG; Iafrate AJ; Dietrich J; Batchelor TT; Gerstner ER; Kaelin WG; Chi AS; Rosen BR; Cahill DP
    Clin Cancer Res; 2016 Apr; 22(7):1632-41. PubMed ID: 26534967
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reliable diagnosis of IDH-mutant glioblastoma by 2-hydroxyglutarate detection: a study by 3-T magnetic resonance spectroscopy.
    Natsumeda M; Motohashi K; Igarashi H; Nozawa T; Abe H; Tsukamoto Y; Ogura R; Okada M; Kobayashi T; Aoki H; Takahashi H; Kakita A; Okamoto K; Nakada T; Fujii Y
    Neurosurg Rev; 2018 Apr; 41(2):641-647. PubMed ID: 28956184
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of 2-hydroxyglutarate in IDH-mutated glioma patients by in vivo spectral-editing and 2D correlation magnetic resonance spectroscopy.
    Andronesi OC; Kim GS; Gerstner E; Batchelor T; Tzika AA; Fantin VR; Vander Heiden MG; Sorensen AG
    Sci Transl Med; 2012 Jan; 4(116):116ra4. PubMed ID: 22238332
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 2-Hydroxyglutarate Detection by Short Echo Time Magnetic Resonance Spectroscopy in Routine Imaging Study of Brain Glioma at 3.0 T.
    Crisi G; Filice S; Michiara M; Crafa P; Lana S
    J Comput Assist Tomogr; 2018; 42(3):469-474. PubMed ID: 29287025
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Accumulation of 2-hydroxyglutarate in gliomas correlates with survival: a study by 3.0-tesla magnetic resonance spectroscopy.
    Natsumeda M; Igarashi H; Nomura T; Ogura R; Tsukamoto Y; Kobayashi T; Aoki H; Okamoto K; Kakita A; Takahashi H; Nakada T; Fujii Y
    Acta Neuropathol Commun; 2014 Nov; 2():158. PubMed ID: 25376594
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rapid detection of 2-hydroxyglutarate in frozen sections of IDH mutant tumors by MALDI-TOF mass spectrometry.
    Longuespée R; Wefers AK; De Vita E; Miller AK; Reuss DE; Wick W; Herold-Mende C; Kriegsmann M; Schirmacher P; von Deimling A; Pusch S
    Acta Neuropathol Commun; 2018 Mar; 6(1):21. PubMed ID: 29499756
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In Vivo 2-Hydroxyglutarate Monitoring With Edited MR Spectroscopy for the Follow-up of
    Di Stefano AL; Nichelli L; Berzero G; Valabregue R; Touat M; Capelle L; Pontoizeau C; Bielle F; Lerond J; Giry M; Villa C; Baussart B; Dehais C; Galanaud D; Baldini C; Savatovsky J; Dhermain F; Deelchand DK; Ottolenghi C; Lehéricy S; Marjańska M; Branzoli F; Sanson M
    Neurology; 2023 Jan; 100(1):e94-e106. PubMed ID: 36180241
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Test-retest reproducibility of neurochemical profiles with short-echo, single-voxel MR spectroscopy at 3T and 7T.
    Terpstra M; Cheong I; Lyu T; Deelchand DK; Emir UE; Bednařík P; Eberly LE; Öz G
    Magn Reson Med; 2016 Oct; 76(4):1083-91. PubMed ID: 26502373
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In-Vivo Proton Magnetic Resonance Spectroscopy of 2-Hydroxyglutarate in Isocitrate Dehydrogenase-Mutated Gliomas: A Technical Review for Neuroradiologists.
    Kim H; Kim S; Lee HH; Heo H
    Korean J Radiol; 2016; 17(5):620-32. PubMed ID: 27587950
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vivo
    Branzoli F; Deelchand DK; Sanson M; Lehéricy S; Marjańska M
    Magn Reson Med; 2019 Oct; 82(4):1259-1265. PubMed ID: 31131476
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Measurement of glycine in human brain by triple refocusing 1H-MRS in vivo at 3.0T.
    Choi C; Bhardwaj PP; Seres P; Kalra S; Tibbo PG; Coupland NJ
    Magn Reson Med; 2008 Jan; 59(1):59-64. PubMed ID: 18050319
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection of "oncometabolite" 2-hydroxyglutarate by magnetic resonance analysis as a biomarker of IDH1/2 mutations in glioma.
    Kalinina J; Carroll A; Wang L; Yu Q; Mancheno DE; Wu S; Liu F; Ahn J; He M; Mao H; Van Meir EG
    J Mol Med (Berl); 2012 Oct; 90(10):1161-1171. PubMed ID: 22426639
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Volumetric relationship between 2-hydroxyglutarate and FLAIR hyperintensity has potential implications for radiotherapy planning of mutant IDH glioma patients.
    Jafari-Khouzani K; Loebel F; Bogner W; Rapalino O; Gonzalez GR; Gerstner E; Chi AS; Batchelor TT; Rosen BR; Unkelbach J; Shih HA; Cahill DP; Andronesi OC
    Neuro Oncol; 2016 Nov; 18(11):1569-1578. PubMed ID: 27382115
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vivo detection of citrate in brain tumors by 1H magnetic resonance spectroscopy at 3T.
    Choi C; Ganji SK; Madan A; Hulsey KM; An Z; Zhang S; Pinho MC; DeBerardinis RJ; Bachoo RM; Maher EA
    Magn Reson Med; 2014 Aug; 72(2):316-23. PubMed ID: 24123337
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Repeatability of proton magnetic resonance spectroscopy of the brain at 7 T: effect of scan time on semi-localized by adiabatic selective refocusing and short-echo time stimulated echo acquisition mode scans and their comparison.
    Okada T; Kuribayashi H; Kaiser LG; Urushibata Y; Salibi N; Seethamraju RT; Ahn S; Thuy DHD; Fujimoto K; Isa T
    Quant Imaging Med Surg; 2021 Jan; 11(1):9-20. PubMed ID: 33392007
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In-vivo brain H1-MR-Spectroscopy identification and quantification of 2-hydroxyglutarate in L-2-Hydroxyglutaric aciduria.
    Anghileri E; Bertolino N; Salsano E; Antelmi L; Carpinelli P; Castellotti B; Zucca I; Gellera C; Bisogno R; Caccia C; Cuccarini V
    Brain Res; 2016 Oct; 1648(Pt A):506-511. PubMed ID: 27543339
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.